So good afternoon everyone. My name is Hannah Karanka. And today I would like to present to you in my project computer discovery of novel drugs. The technologies use it as a project are progressive and use it worldwide. Recent research showed the drug design market is activity development.

The global drug discovery service market size is projected to reach $21 billion by 2025 by 11 and $1 billion in 2020 cigr of 14% during the forecast period. Growing area expenditure in the pharmaceutical and biopharmaceutical industry. This necessitates an increasing demand of certain analysis, test and clinical trial diseases. Initiatives for research on rare diseases are often drugs and focus on the drug discovery are driving the growth of the global drug discovery market. There is the industry growing in biology, patent experience and image and economics is expected to provide a wide range of growth opportunity to players in the market. Uh As you can see, I and my team are professional from various benches of science such as the chemistry, computer science, biology, mathematics and physics. That is why we are capable of working this multidisciplinary projects such as computer added drug design. Our team has extensive experience in using such molecular modeling tools as molecular docking molecular for searching and so on. In recent years, our team has identified a series of no HIV and inhibitors K foods mimicking HIV neti antibodies. Number of bits are built to resin as potential inhibitors and so on. Moreover, recently, we have discovered small drugs compound as potential incubators of SARS COV two main projects.

What is the more important we develop a future of approach in order to identify potential featured incubators to new biological target. We already had a successful project with the Fudan University joint developing initiatives and the Academy of Science. Our key publications were published in high cited international journals.

The first results of our work on COVID-19 issue were published in the journal of the from Metics and Computing Biology. This impact factor higher than three. This is the present day. The article issued about more than 2000 times and downloaded more than 600 times. We consider presentation and popularization of our result is an extremely important part of our work. Our team members actively participated in the conference and scientific competition. This drives and maintain of our competence of international level as a result. Our team is among the finals of the International JD COVID-19 challenge and the final I expected in August. So here I would like to tell you about our main work scheme on the first step which is the target is that to reconstruct the pharmaco model and carry out virtual screening on the basis of it. Then we sort identified compounds in the order then efficiently by the means of molecular dogging tools. On the next step, we obtain result as a teaching data set for our neural network and generate more potential active compounds. The last step in the evaluation of the best compounds is molecular dynamics as well as quantum chemistry tools. Since that method gives the most reliable results. Additionally, they provide a comprehensive description of binding prophy and under met properties for the best compounds in a night show.

The result of our work is a list of potential incubators to the certain biological target that are to be synthesized and tested extremely accompanied with a detailed information about their activity. I have to tell that nowadays we can use as a neural network on all steps uh which you can see from our area. The green part is that what we are doing. The um the blue part is what we expect since our approach is a theoretical, one is at much less cost and time demanding at least two times faster and six times cheaper in comprehension to the classical approach. As you can see from the table of the slide, every step of which structure to discovery is significantly accelerated by the needs of molecular model and common fors uh the type of cooper operation. What we are looking for is a join research and project joint publication, international journal and join patent. So what we can offer, they offer a full cycle of computer drug discovery cycle as well as some particular expertise in any of the film methods. Above of any diseases for the biological trigger is no longer posted in the protein data bank to sum up as a result of our work is a lead of potential individuals to certain biological targets.

This is the drug candidates are ready for laboratory expertise for the future in individual and invivo modification. So thank you for your attention. We'll be glad to listen and to get your questions here or by mail link it in or if you would like to visit our website.